Borg, David Larsson, Anna Hedner, Charlotta Nodin, Bjรถrn Johnsson, Anders Jirstrรถm, Karin MOESM3 of Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma Additional file 3: Table S3. Correlation of PODXL score/expression between whole tissue sections and corresponding TMA cores from resected primary tumors. Esophageal adenocarcinoma;Gastric adenocarcinoma;Neoadjuvant chemotherapy;PODXL 2018-10-24
    https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Podocalyxin-like_protein_as_a_predictive_biomarker_for_benefit_of_neoadjuvant_chemotherapy_in_resectable_gastric_and_esophageal_adenocarcinoma/7251113
10.6084/m9.figshare.7251113.v1